GB0625682D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0625682D0
GB0625682D0 GB0625682A GB0625682A GB0625682D0 GB 0625682 D0 GB0625682 D0 GB 0625682D0 GB 0625682 A GB0625682 A GB 0625682A GB 0625682 A GB0625682 A GB 0625682A GB 0625682 D0 GB0625682 D0 GB 0625682D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0625682A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Cancer Research Technology Ltd
Astex Therapeutics Ltd
AstraZeneca AB
Original Assignee
Institute of Cancer Research
Cancer Research Technology Ltd
Astex Therapeutics Ltd
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research, Cancer Research Technology Ltd, Astex Therapeutics Ltd, AstraZeneca AB filed Critical Institute of Cancer Research
Priority to GB0625682A priority Critical patent/GB0625682D0/en
Publication of GB0625682D0 publication Critical patent/GB0625682D0/en
Priority to ARP070105690A priority patent/AR064415A1/en
Priority to TW096148757A priority patent/TW200833694A/en
Priority to MX2009006650A priority patent/MX2009006650A/en
Priority to EP07848737A priority patent/EP2125820A1/en
Priority to KR1020097014899A priority patent/KR20090104030A/en
Priority to PCT/GB2007/050777 priority patent/WO2008075110A1/en
Priority to JP2009542237A priority patent/JP2010513453A/en
Priority to CN200780050862A priority patent/CN101627042A/en
Priority to CA002672841A priority patent/CA2672841A1/en
Priority to US12/519,993 priority patent/US20100120798A1/en
Priority to AU2007335969A priority patent/AU2007335969A1/en
Priority to UY30823A priority patent/UY30823A1/en
Priority to BRPI0721124-4A priority patent/BRPI0721124A2/en
Priority to CL2007003792A priority patent/CL2007003792A1/en
Priority to PE2008000081A priority patent/PE20081680A1/en
Priority to NO20092341A priority patent/NO20092341L/en
Priority to EC2009009446A priority patent/ECSP099446A/en
Priority to ZA200904327A priority patent/ZA200904327B/en
Ceased legal-status Critical Current

Links

GB0625682A 2006-12-21 2006-12-21 Pharmaceutical compounds Ceased GB0625682D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0625682A GB0625682D0 (en) 2006-12-21 2006-12-21 Pharmaceutical compounds
ARP070105690A AR064415A1 (en) 2006-12-21 2007-12-18 PIRROLO-PIPERIDIN AND PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN DISORDERS AND / OR DISEASES MEDIATED BY PKA AND PKB.
TW096148757A TW200833694A (en) 2006-12-21 2007-12-19 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
BRPI0721124-4A BRPI0721124A2 (en) 2006-12-21 2007-12-20 COMPOSITION, USE OF THE SAME, METHODS FOR PROPHYLAXY OR TREATMENT OF A STATE OR DISEASE, TO TREAT A DISEASE OR CONDITION, TO INHIBIT PROTEIN KINASE, TO MODULATE A CELL PROCESS, TO RELIEVE OR REDUCE THE INCIDENCE OR DISEASE, FOR DIAGNOSIS AND TREATMENT OF A DISEASE STATE OR CONDITION AND FOR MODULATING PROTEIN KINASE BE / OR PROTEIN KINASE A, AND PHARMACEUTICAL COMPOSITION
CN200780050862A CN101627042A (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
UY30823A UY30823A1 (en) 2006-12-21 2007-12-20 SUBSTITUTED PIPERIDINS CONTAINING A FRACTION OF HETEROARILAMIDA OR HETEROARILFENILO
KR1020097014899A KR20090104030A (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
PCT/GB2007/050777 WO2008075110A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
JP2009542237A JP2010513453A (en) 2006-12-21 2007-12-20 Substituted piperidines containing heteroarylamide or heteroarylphenyl moieties
MX2009006650A MX2009006650A (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety.
CA002672841A CA2672841A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
US12/519,993 US20100120798A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
AU2007335969A AU2007335969A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
EP07848737A EP2125820A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
CL2007003792A CL2007003792A1 (en) 2006-12-21 2007-12-21 COMPOUNDS DERIVED FROM SUBSTITUTED PIPERIDINS CONTAINING A PORTION OF HETEROARILAMIDE OR HETEROARILFENIL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
PE2008000081A PE20081680A1 (en) 2006-12-21 2008-01-02 SUBSTITUTE PIPERIDINS CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL COMPONENT
NO20092341A NO20092341L (en) 2006-12-21 2009-06-18 Substituted piperidines containing a heteroarylamide or a heteroarylphenyl group
EC2009009446A ECSP099446A (en) 2006-12-21 2009-06-19 SUBSTITUTED PIPERIDINS CONTAINING A HETEROARILAMIDE OR HETEROARILFENILO UNIT
ZA200904327A ZA200904327B (en) 2006-12-21 2009-06-19 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0625682A GB0625682D0 (en) 2006-12-21 2006-12-21 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0625682D0 true GB0625682D0 (en) 2007-01-31

Family

ID=37734730

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0625682A Ceased GB0625682D0 (en) 2006-12-21 2006-12-21 Pharmaceutical compounds

Country Status (3)

Country Link
CN (1) CN101627042A (en)
GB (1) GB0625682D0 (en)
ZA (1) ZA200904327B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105037365A (en) * 2015-06-25 2015-11-11 贵州大学 N-substituted-1-(6-substituted-9H-purine)piperidine-4-carboxamide derivatives and application thereof

Also Published As

Publication number Publication date
ZA200904327B (en) 2010-06-30
CN101627042A (en) 2010-01-13

Similar Documents

Publication Publication Date Title
HK1127356A1 (en) Pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0709031D0 (en) Pharmaceutical compounds
IL201366A0 (en) Pharmaceutical compounds
GB0721095D0 (en) Pharmaceutical compounds
EP1992348A4 (en) Pharmaceutical combination
GB0707087D0 (en) Pharmaceutical compounds
GB0725214D0 (en) Pharmaceutical compounds
GB0704932D0 (en) Pharmaceutical compounds
GB0721669D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0611565D0 (en) Pharmaceutical compounds
GB0625668D0 (en) Pharmaceutical compounds
GB0625431D0 (en) Pharmaceutical compounds
GB0615299D0 (en) Pharmaceutical compounds
GB0615293D0 (en) Pharmaceutical compounds
GB0614456D0 (en) Pharmaceutical compounds
GB0613520D0 (en) Pharmaceutical compounds
GB0608162D0 (en) Pharmaceutical Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)